Assert-IQ ICM

Designed to Outperform, Built to Outlast

MAT-2403640 v1.0 | Item approved for U.S. use only. ©2024 Abbott. All Rights Reserved.

Clinical Evidence

Discover the clinical performance of Assert-IQ™ Insertable Cardiac Monitor (ICM) with our informative resources. This cutting-edge cardiac monitor generates clinically actionable data that matters for physicians and patients.

Our clinical compendium presents a detailed summary of the product and clinical data. It also provides essential information on the latest clinical evidence supporting the effectiveness of Assert-IQ ICM in diagnosing and managing cardiac arrhythmias.

Explore our resources to learn more about how Assert-IQ ICM can assist you in providing better care for your patients.

Insertable Cardiac Monitoring Results in Higher Rates of Atrial Fibrillation Diagnosis and Oral Anticoagulation Prescription after Ischaemic Stroke (2023)

Real-world clinical evidence from a U.S. nationwide study shows that insertable cardiac monitoring results in higher rates of atrial fibrillation (AF) diagnosis and oral anticoagulation implementation compared to external cardiac monitoring after cryptogenic stroke (CS). Patients with ICMs were almost 3 times more likely to be diagnosed with AF and to be prescribed an OAC compared to patients who only received an ECM.1

Novel Algorithms Improve Arrhythmia Detection Accuracy in Insertable Cardiac Monitors (2023)

This article from the Journal of Cardiovascular Electrophysiology, is a retrospective analysis using episodes triggered by real‐world ICM devices to develop and evaluate new discrimination algorithms that further reduce false detections of atrial fibrillation (AF), pause, and tachycardia episodes in Abbott's next-generation ICM system. The evaluation showed that newly developed algorithms substantially reduced false episodes while having minimal impact on true ones, as compared to the predicate Abbott ICM algorithms. Implementation of the enhanced algorithms in an ICM system may lead to improved detection accuracy, device clinic efficiency, and longer battery longevity.2

Powering Hearts Beat to Beat

Sign up to hear about our technology, education opportunities, and more.

Read the Latest Blog Article

Stay up to date with recent news, product highlights, and case studies.

References:

1. Boriani G, Auricchio A, Botto GL, et al. Insertable Cardiac Monitoring Results in Higher Rates of Atrial Fibrillation Diagnosis and Oral Anticoagulation Prescription after Ischaemic Stroke. EP Europace. 2023; euad212, doi.org/10.1093/europace/euad212.

2. Gopinathannair R, Shehata MM, Afzal MR, et al. Novel Algorithms Improve Arrhythmia Detection Accuracy in Insertable Cardiac Monitors. Journal of Cardiovascular Electrophysiology. July 2023. doi:10.1111/jce.16007.

MAT-2303941 v5.0